The crude chloroform bark extract of an undescribed species of Salacia from Monteverde, Costa Rica, showed cruzain inhibitory activity (IC 50 = 11.4 ± 0.6 μg/mL). Activity-directed chromatographic separation led to isolation of four active friedelane triterpenoids, 25,28-dihydroxyfriedelin, canophyllol, tingenone, and the novel 29-hydroxyfriedelan-3-on-28-al.
Chagas disease, widely distributed in Latin America, is caused by the parasitic protozoan Trypanosoma cruzi. The disease currently afflicts approximately 16-18 million people with 90-100 million at risk [1] . Patients with chronic Chagas disease, for which there is currently no effective treatment, become progressively ill and ultimately die, usually from heart failure. Both nifurtimox and benznidazole are used for clinical treatment of the disease, but there are severe side effects and they are ineffective in chronic cases, so there is a need to find new drugs with greater efficacy and less toxicity [2] . The cysteine protease cruzain has been identified as a potential target for drug discovery [3] .
We have recently begun examining higher plants from Monteverde, Costa Rica, for natural products as potential chemotherapeutic agents for treatment of Chagas disease [4] . In this work, we describe the isolation of cruzain-inhibitory triterpenoids from Salacia new species "liana" [5] .
The crude chloroform bark extract of Salacia sp. "liana" showed very promising cruzain inhibitory activity with an IC 50 of 11.4 ± 0.6 μg/mL. The bark extract was subjected to activity-directed preparative flash chromatography on a silica gel column, eluting with hexane/ethyl acetate. Four inhibitory compounds were isolated and purified. NMR spectral analysis revealed the compounds to be the known friedelane triterpenoids canophyllol [6] , (IC 50 = 87.4 ± 0.3 μg/mL), 25,28-dihydroxyfriedelin [7] , (IC 50 = 154 ± 0.9 μg/mL), the quinone methide tingenone [8] , (IC 50 = 79.8 ± 6.7 μg/mL), and the novel 29-hydroxyfriedelan-3-on-28-al, 1 (IC 50 = 71.1 ± 0.9 μg/mL). The diastereomeric 30-hydroxyfriedelan-3-on-28-al (as a mixture of cyclic hemiacetals) had been isolated previously from this Salacia species [9] . Friedelin [10] was also isolated but was inactive (IC 50 > 500 μg/mL).
Experimental
The stem bark of Salacia sp. nov. "liana" was collected from several individuals growing in lower Table 1 ).
The crude bark extract, chromatographic fractions, and purified active compound were tested for inhibitory activity against recombinant cruzain [11] using a fluorescence assay as previously described [4] . NMR measurements were carried out in CDCl 3 using a Varian UNITY INOVA 500 MHz NMR.
